The Dallas Cowboys have constantly had players on their team being suspended for various reasons. On Thursday, Robert Quinn was suspended for the first two games of the season for violating the league's performance-enhancing substance policy.
After the suspension was handed down, Quinn's agent was “extremely disappointed” in the NFL's decision to suspend his client. Sean Kiernan, Quinn's agent, released his full statement on the matter on Twitter.
Statement re: Robert Quinn pic.twitter.com/EY5D5KJslJ
— Sean Kiernan (@SKiernan78) August 8, 2019
According to the reports, Quinn was suspended for testing positive for probenecid. Probenecid is a medication that can be used as a masking agent for steroids. Quinn doesn't use any supplements but he does take prescription medication to prevent seizures.
Per Kiernan, Quinn never used probenecid and the agent said that the NFL even said that they didn't believe that Quinn was doping intentionally. Nonetheless, the NFL slapped a two-game suspension on Quinn for the 2019 season.
During Wednesday's practice, Quinn suffered a fractured hand in practice and would require surgery. The veteran defensive end received surgery on Thursday for two fractures in his left hand. Despite receiving surgery, he was expected to be ready before the Cowboys regular-season opener on September 8th.
Earlier this offseason, Dallas made a trade to acquire Quinn from the Miami Dolphins. They made the move for Quinn in hopes he could provide some pressure off of the edge alongside Demarcus Lawrence.
In his only season in Miami last year, Quinn had 6.5 sacks, nine tackles for loss, 15 hits on the quarterback, and two forced fumbles. The Cowboys will have to wait for Quinn to make his return in Week 3 against the Miami Dolphins on September 22nd.
Follow Us
Subscribe